Barclays’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.5M | Buy |
178,611
+35,730
| +25% | +$1.3M | ﹤0.01% | 1424 |
|
|
2025
Q1 | $5.18M | Sell |
142,881
-63,227
| -31% | -$2.29M | ﹤0.01% | 1393 |
|
|
2024
Q4 | $8.67M | Buy |
206,108
+126,562
| +159% | +$5.32M | ﹤0.01% | 1212 |
|
|
2024
Q3 | $4.42M | Buy |
79,546
+16,633
| +26% | +$924K | ﹤0.01% | 1617 |
|
|
2024
Q2 | $2.59M | Sell |
62,913
-55,860
| -47% | -$2.3M | ﹤0.01% | 1535 |
|
|
2024
Q1 | $5.55M | Sell |
118,773
-47,969
| -29% | -$2.24M | ﹤0.01% | 1319 |
|
|
2023
Q4 | $7.97M | Buy |
166,742
+46,049
| +38% | +$2.2M | ﹤0.01% | 1184 |
|
|
2023
Q3 | $4.3M | Buy |
120,693
+18,552
| +18% | +$661K | ﹤0.01% | 1217 |
|
|
2023
Q2 | $4.71M | Buy |
102,141
+10,474
| +11% | +$483K | ﹤0.01% | 1256 |
|
|
2023
Q1 | $3.68M | Sell |
91,667
-32,920
| -26% | -$1.32M | ﹤0.01% | 1256 |
|
|
2022
Q4 | $5.77M | Buy |
124,587
+8,997
| +8% | +$417K | ﹤0.01% | 1039 |
|
|
2022
Q3 | $4.79M | Buy |
115,590
+95,515
| +476% | +$3.96M | 0.01% | 1126 |
|
|
2022
Q2 | $1.2M | Buy |
20,075
+473
| +2% | +$28.2K | ﹤0.01% | 1930 |
|
|
2022
Q1 | $1.42M | Sell |
19,602
-3,828
| -16% | -$278K | ﹤0.01% | 2052 |
|
|
2021
Q4 | $1.97M | Buy |
23,430
+18,715
| +397% | +$1.57M | ﹤0.01% | 1810 |
|
|
2021
Q3 | $425K | Sell |
4,715
-19,665
| -81% | -$1.77M | ﹤0.01% | 2669 |
|
|
2021
Q2 | $2.33M | Sell |
24,380
-47,296
| -66% | -$4.51M | ﹤0.01% | 1630 |
|
|
2021
Q1 | $8.16M | Buy |
71,676
+48,152
| +205% | +$5.48M | ﹤0.01% | 905 |
|
|
2020
Q4 | $3.26M | Sell |
23,524
-74,107
| -76% | -$10.3M | ﹤0.01% | 1262 |
|
|
2020
Q3 | $8.03M | Buy |
97,631
+63,161
| +183% | +$5.19M | ﹤0.01% | 785 |
|
|
2020
Q2 | $2.7M | Sell |
34,470
-117,302
| -77% | -$9.17M | ﹤0.01% | 1274 |
|
|
2020
Q1 | $6.74M | Buy |
151,772
+38,561
| +34% | +$1.71M | 0.01% | 757 |
|
|
2019
Q4 | $4.84M | Buy |
113,211
+86,164
| +319% | +$3.68M | ﹤0.01% | 1243 |
|
|
2019
Q3 | $1.16M | Sell |
27,047
-8,287
| -23% | -$354K | ﹤0.01% | 2164 |
|
|
2019
Q2 | $2.24M | Buy |
35,334
+11,670
| +49% | +$741K | ﹤0.01% | 1708 |
|
|
2019
Q1 | $1.64M | Buy |
23,664
+17,400
| +278% | +$1.21M | ﹤0.01% | 1712 |
|
|
2018
Q4 | $273K | Sell |
6,264
-20,985
| -77% | -$915K | ﹤0.01% | 2587 |
|
|
2018
Q3 | $2.08M | Buy |
27,249
+16,246
| +148% | +$1.24M | ﹤0.01% | 1747 |
|
|
2018
Q2 | $846K | Sell |
11,003
-602
| -5% | -$46.3K | ﹤0.01% | 1970 |
|
|
2018
Q1 | $592K | Buy |
11,605
+2,622
| +29% | +$134K | ﹤0.01% | 2175 |
|
|
2017
Q4 | $416K | Buy |
8,983
+5,594
| +165% | +$259K | ﹤0.01% | 2221 |
|
|
2017
Q3 | $180K | Buy |
3,389
+1,747
| +106% | +$92.8K | ﹤0.01% | 2442 |
|
|
2017
Q2 | $102K | Sell |
1,642
-21,943
| -93% | -$1.36M | ﹤0.01% | 2756 |
|
|
2017
Q1 | $1.6M | Buy |
23,585
+18,282
| +345% | +$1.24M | ﹤0.01% | 1327 |
|
|
2016
Q4 | $373K | Sell |
5,303
-29,740
| -85% | -$2.09M | ﹤0.01% | 1986 |
|
|
2016
Q3 | $2.49M | Buy |
35,043
+32,566
| +1,315% | +$2.31M | ﹤0.01% | 973 |
|
|
2016
Q2 | $121K | Sell |
2,477
-2,562
| -51% | -$125K | ﹤0.01% | 2272 |
|
|
2016
Q1 | $318K | Buy |
5,039
+3,542
| +237% | +$224K | ﹤0.01% | 1899 |
|
|
2015
Q4 | $167K | Sell |
1,497
-10,365
| -87% | -$1.16M | ﹤0.01% | 2121 |
|
|
2015
Q3 | $1.14M | Sell |
11,862
-8,883
| -43% | -$853K | ﹤0.01% | 1347 |
|
|
2015
Q2 | $2.12M | Buy |
20,745
+20,010
| +2,722% | +$2.04M | ﹤0.01% | 1143 |
|
|
2015
Q1 | $45K | Buy |
735
+65
| +10% | +$3.98K | ﹤0.01% | 2794 |
|
|
2014
Q4 | $29K | Buy |
670
+426
| +175% | +$18.4K | ﹤0.01% | 3267 |
|
|
2014
Q3 | $14K | Buy |
244
+125
| +105% | +$7.17K | ﹤0.01% | 3583 |
|
|
2014
Q2 | $6K | Sell |
119
-62
| -34% | -$3.13K | ﹤0.01% | 3850 |
|
|
2014
Q1 | $9K | Buy |
+181
| New | +$9K | ﹤0.01% | 3819 |
|